Company intelligence / Profile preview
Sayre Therapeutics
- Ownership
- Private
- Employees
- ~34
- Development stage
- Other
Overview
Sayre Therapeutics is a commercial-stage specialty healthcare company that in-licenses and commercializes novel oncology, rare and orphan disease medicines, drug-delivery devices, biosimilars, niche generics, and companion/other diagnostics across India, South Asia, and parts of Southeast Asia; detailed program-level clinical results are not publicly described.
- Therapeutic areas
- OncologyImmunologyRheumatologyRare Diseases
- Modalities
- Small moleculeRecombinant proteinMonoclonal antibodyDrug-delivery deviceDiagnostic
- Industry
- Biotech
Drug pipeline
2 assets1 more asset in the full pipeline.
Partnerships
Beyond the preview
Go deeper on Sayre Therapeutics.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Sayre Therapeutics.